非射血分数降低心衰患者冠脉与外周微血管内皮功能障碍评估
前瞻性注册研究纳入142例非射血分数降低心衰患者,用CFR和RHI分别评估冠脉与外周微血管内皮功能障碍。CMD患病率51.4%,MED患病率40.1%,RHI与CFR正相关,心率增快是CMD危险因素,RHI上升是CMD保护因素,CFR上升是MED保护因素。
要点
- nHFrEF患者CMD患病率51.4%,MED患病率40.1%,均较高。
- 心率增快是CMD危险因素,RHI上升是CMD保护因素。
- CFR上升是MED保护因素,RHI与CFR呈正相关。
核心结论
- nHFrEF患者CMD和MED患病率均较高,两者具有一定正相关性。
- 心率增快和RHI上升分别是CMD的危险和保护因素,CFR上升是MED的保护因素。
- 微血管内皮功能障碍可能是nHFrEF患者的潜在治疗靶点。
研究设计与样本
- 前瞻性注册研究,纳入2021年12月至2023年12月复旦大学附属中山医院住院的nHFrEF患者。
- 共入组142例,年龄69.0(59.0,74.0)岁,男性66.9%(95/142)。
- 依据CFR<2.5或≥2.5分为CMD组与无CMD组,依据RHI<1.67或≥1.67分为MED组与无MED组。
主要发现
- CMD组73例、无CMD组69例,MED组57例、无MED组85例。
- 单因素分析示心率增快、慢性肾脏病、房颤、NT-proBNP升高、尿白蛋白/肌酐比值增加是CMD危险因素,RHI上升是保护因素。
- 多因素分析示心率增快和RHI上升仍分别是CMD的危险和保护因素,CFR上升仍是MED的保护因素。
- Spearman分析示CFR与lg尿白蛋白/肌酐比值、lg心肌肌钙蛋白T、lgNT-proBNP及心率呈负相关,RHI与CFR呈正相关。
关键数值与推荐
- CMD定义为CFR<2.5,MED定义为RHI<1.67。
- CMD患病率51.4%(73/142),MED患病率40.1%(57/142)。
临床怎么用
- 对nHFrEF患者应关注CMD和MED的高患病率,可考虑用CFR和RHI评估微血管内皮功能。
- 心率增快提示CMD风险升高,RHI上升提示CMD风险降低,CFR上升提示MED风险降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the prevalence, potential risk factors, and correlation between coronary and peripheral microvascular dysfunction in heart failure with non-reduced ejection fraction (nHFrEF) patients. Methods: This was a prospective registry study. nHFrEF patients admitted to Zhongshan Hospital affiliated with Fudan University from December 2021 to December 2023 were enrolled. According to coronary flow reserve (CFR) or reactive congestion index (RHI), enrolled patients were divided into coronary microvascular endothelial dysfunction (CMD) group (CFR<2.5) and no CMD group (CFR≥2.5) or peripheral microvascular endothelial dysfunction (MED) group (RHI<1.67) and no MED group (RHI≥1.67). Patients' general information, laboratory and auxiliary examination data were collected. Univariate and multivariate logistic regression were used to analyze the influencing factors of CMD and MED in nHFrEF patients, and Spearman correlation analysis was used to evaluate the correlation between MED and CMD. Results: A total of 142 nHFrEF patients were enrolled, aged 69.0 (59.0, 74.0) years, with a male proportion of 66.9% (95/142). The grouping results were as follows: (1) According to CFR, there were 73 cases in the CMD group and 69 cases in the no CMD group; (2) According to RHI, there were 57 cases in the MED group and 85 cases in the no MED group. The prevalence of CMD and MED in this study was 51.4% (73/142) and 40.1% (57/142), respectively. Univariate logistic regression analysis showed that increased heart rate, chronic kidney disease, atrial fibrillation, elevated N-terminal pro-B type natriuretic peptide levels, and increased urinary albumin/creatinine ratio were risk factors for CMD, while increased RHI was a protective factor for CMD; Atrial fibrillation is a risk factor for MED, while increased CFR is a protective factor for MED. Incorporating clinically significant variables from univariate analysis into multivariate analysis, the results showed that increased heart rate and elevated RHI remained risk and protective factors for CMD, respectively; increased CFR remains a protective factor for MED. Spearman correlation analysis showed that CFR was negatively correlated with lg urinary albumin/creatinine ratio, lg cardiac troponin T, lg N-terminal pro-B type natriuretic peptide, and heart rate; RHI is positively correlated with CFR. Conclusions: The prevalence of CMD and MED in nHFrEF patients is high, and the two have a certain positive correlation. Increased heart rate and RHI are risk and protective factors for CMD, respectively, while increased CFR is a protective factor for MED. MED may be a potential therapeutic target for nHFrEF patients. 目的: 评估非射血分数降低的心力衰竭患者冠状动脉和外周微血管功能障碍的患病率、危险因素及二者相关性。 方法: 本研究为前瞻性注册研究。纳入2021年12月至2023年12月于复旦大学附属中山医院住院的非射血分数降低的心力衰竭患者。依据冠状动脉血流储备(CFR)或反应性充血指数(RHI)将入组患者分为冠状动脉微血管内皮功能障碍(CMD)组(CFR<2.5)和无CMD组(CFR≥2.5)或外周微血管内皮功能障碍(MED)组(RHI<1.67)和无MED组(RHI≥1.67)。收集患者的一般资料、实验室及辅助检查数据。采用单因素和多因素logistic回归分析非射血分数降低的心力衰竭患者发生CMD和MED的影响因素,应用Spearman相关分析评价非射血分数降低的心力衰竭患者MED和CMD间的相关性。 结果: 共入组142例非射血分数降低的心力衰竭患者,年龄69.0(59.0,74.0)岁,男性占比66.9%(95/142)。分组结果为:(1)依据CFR:CMD组73例,无CMD组69例;(2)依据RHI:MED组57例,无MED组85例。本研究中,CMD和MED的患病率分别为51.4%(73/142)和40.1%(57/142)。单因素logistic回归分析显示,心率增快、慢性肾脏病、心房颤动(房颤)、N末端B型利钠肽原水平升高,尿白蛋白/肌酐比值和舒张期室间隔厚度增加是CMD的危险因素,堪萨斯城心肌病调查问卷评分、左心房内径和RHI上升是CMD的保护因素;房颤和血红蛋白升高是MED的危险因素,CFR上升是MED的保护因素。将单因素分析中有临床意义的变量纳入多因素分析,结果显示心率增快和RHI上升仍分别是CMD的危险和保护因素;CFR上升仍是MED的保护因素。Spearman相关性分析显示CFR与lg尿白蛋白/肌酐比值、lg心肌肌钙蛋白T、lgN末端B型利钠肽原及心率呈负相关;RHI与CFR呈正相关。 结论: 非射血分数降低的心力衰竭患者CMD和MED患病率均较高,且两者具有一定的正相关性。心率增快和RHI上升分别是CMD的危险和保护因素,CFR上升是MED的保护因素。微血管内皮功能障碍可能是非射血分数降低的心力衰竭患者的潜在治疗靶点。.
引用
- Wang, Han, Xie, et al. [Evaluation of coronary and peripheral microvascular endothelial dysfunction in patients with heart failure with non-reduced ejection fraction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2025. PMID: 39965850. doi:10.3760/cma.j.cn112148-20241211-00777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。